Aditxt
$0.010900
151
-$0.00-15.5% Tuesday 20:00
Statistics
Day High
0.016
Day Low
0.009
52W High
53,453.52
52W Low
0.009
Volume
821,844,338
Avg. Volume
-
Mkt Cap
6,093.1
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2SepExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-30,188.81%Profit Margin
Unprofitable268,000Revenue
-80.91MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ADTX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.46B
Moderna
MRNA
Mkt Cap19.8B
BioNTech
BNTX
Mkt Cap22.9B
Pfizer
PFE
Mkt Cap149.38B
Johnson & Johnson
JNJ
Mkt Cap579.83B
Gilead Sciences
GILD
Mkt Cap155.93B
Regeneron Pharmaceuticals
REGN
Mkt Cap64.18B
Vertex Pharmaceuticals
VRTX
Mkt Cap112.92B
AMGEN
AMGN
Mkt Cap191.7B
Novartis
NVS
Mkt Cap292.07B
About
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions. Aditxt also pioneers Apoptotic DNA Immunotherapy, a nucleic acid-based solution that emulates the body's inherent mechanisms for developing self-tolerance to its own tissues. Additionally, Aditxt is actively researching and developing ADi products with diverse therapeutic applications, such as for organ transplant procedures (including skin grafting), various autoimmune conditions, and allergic reactions. The company holds licensing agreements with esteemed institutions like Loma Linda University and Leland Stanford Junior University. Established in 2017, this Richmond, Virginia-headquartered company was initially known as ADiTx Therapeutics, Inc. before rebranding to Aditxt, Inc. in July 2021.
Show more...
CEO
Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.
Employees
26
Country
United States
ISIN
US0070258696
Listings
0 Comments
Share your thoughts
FAQ
What is Aditxt stock price today?▼
The current price of ADTX is $0.01 USD — it has decreased by -15.5% in the past 24 hours. Watch Aditxt stock price performance more closely on the chart.
What is Aditxt stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aditxt stocks are traded under the ticker ADTX.
Is Aditxt stock price growing?▼
ADTX stock has fallen by -41.08% compared to the previous week, the month change is a -99.36% fall, over the last year Aditxt has showed a -100% decrease.
What is Aditxt market cap?▼
Today Aditxt has the market capitalization of 6,093.1
When is the next Aditxt earnings date?▼
Aditxt is going to release the next earnings report on September 02, 2026.
What were Aditxt earnings last quarter?▼
ADTX earnings for the last quarter are -790.49 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aditxt revenue for the last year?▼
Aditxt revenue for the last year amounts to 268,000 USD.
What is Aditxt net income for the last year?▼
ADTX net income for the last year is -80.91M USD.
How many employees does Aditxt have?▼
As of June 17, 2026, the company has 26 employees.
In which sector is Aditxt located?▼
Aditxt operates in the Health & Wellness sector.
When did Aditxt complete a stock split?▼
The last stock split for Aditxt was on May 18, 2026 with a ratio of 1:27.
Where is Aditxt headquartered?▼
Aditxt is headquartered in Mountain View, United States.